Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Hold
5,100
0.36% 52
2026
Q1
$1.79M Hold
5,100
0.39% 53
2025
Q4
$1.67M Buy
+5,100
New +$1.62M 0.35% 49
2021
Q1
Sell
-1,000
Closed -$230K 75
2020
Q4
$230K Hold
1,000
0.11% 66
2020
Q3
$254K Hold
1,000
0.15% 55
2020
Q2
$236K Hold
1,000
0.17% 50
2020
Q1
$203K Hold
1,000
0.13% 50
2019
Q4
$241K Buy
+1,000
New +$220K 0.14% 48

Other funds holding AMGN

Curtis Advisory Group's AMGN Position: Q2 2026 in Review

Curtis Advisory Group held its Amgen (AMGN) position steady in Q2 2026 at 5,100 shares worth $1.85M. The position accounts for 0.36% of the portfolio, ranked #52.

Curtis Advisory Group first reported a position in AMGN in Q4 2019 and has held it in 8 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Curtis Advisory Group held 5,100 shares of Amgen worth $1.85M as of Q2 2026.
  • Curtis Advisory Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.36% of Curtis Advisory Group's portfolio in Q2 2026, its #52 holding.
  • Curtis Advisory Group first reported a position in Amgen in Q4 2019 and has held it in 8 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Curtis Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.